BioLASCO Taiwan Co., Ltd. (TPEX:6662)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.65
+0.30 (1.02%)
At close: Mar 10, 2026
-11.23%
Market Cap 751.71M
Revenue (ttm) 277.12M
Net Income (ttm) 44.74M
Shares Out 25.61M
EPS (ttm) 1.75
PE Ratio 16.80
Forward PE n/a
Dividend 1.50 (4.99%)
Ex-Dividend Date Aug 7, 2025
Volume 2,410
Average Volume 14,225
Open 29.50
Previous Close 29.35
Day's Range 29.50 - 29.65
52-Week Range 28.60 - 36.70
Beta 0.17
RSI 40.05
Earnings Date Mar 20, 2026

About BioLASCO Taiwan

BioLASCO Taiwan Co., Ltd. operates an animal breeding center to produce specific pathogen-free laboratory mice and rats in Taiwan and internationally. It offers lab animals, such as rat, mice, and others, as well as surgical services; rodents housing, washing solutions, workstations, animal housing and management solutions, lab animal research equipment, clean solution, preclinical imaging system, and experimental equipment; various reagents, including lab animal diagnostic reagent, endotoxin testing system, portable endotoxin testing system, r... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1990
Employees 91
Stock Exchange Taipei Exchange
Ticker Symbol 6662
Full Company Profile

Financial Performance

In 2024, BioLASCO Taiwan's revenue was 292.50 million, an increase of 10.49% compared to the previous year's 264.72 million. Earnings were 44.03 million, a decrease of -11.49%.

Financial Statements

News

There is no news available yet.